NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 36 filers reported holding NRX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,758 | -46.2% | 18,300 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8,848 | -26.6% | 18,300 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $12,062 | -40.6% | 18,300 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $20,313 | +45.1% | 18,300 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $14,000 | +27.3% | 18,300 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $11,000 | -75.6% | 18,300 | 0.0% | 0.00% | -66.7% |
| Q1 2022 | $45,000 | – | 18,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 325,000 | $84,500 | 0.06% |
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $16,455 | 0.00% |
| XTX Topco Ltd | 11,809 | $3,070 | 0.00% |
| United Asset Strategies, Inc. | 18,300 | $4,758 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 160,700 | $41,782 | 0.00% |
| UBS Group AG | 1,210 | $315 | 0.00% |
| NewEdge Advisors, LLC | 7,125 | $1,853 | 0.00% |
| Lido Advisors, LLC | 13,000 | $3,380 | 0.00% |
| OSAIC HOLDINGS, INC. | 11,125 | $2,891 | 0.00% |
| WELLS FARGO & COMPANY/MN | 5,379 | $1,399 | 0.00% |